These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 33080337)

  • 1. Molecular mechanisms of psychiatric diseases.
    Blokhin IO; Khorkova O; Saveanu RV; Wahlestedt C
    Neurobiol Dis; 2020 Dec; 146():105136. PubMed ID: 33080337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Efficacy of atypical antipsychotics in depressive syndromes].
    Quintin P; Thomas P
    Encephale; 2004; 30(6):583-9. PubMed ID: 15738862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulating the serotonin system in the treatment of major depressive disorder.
    Morrissette DA; Stahl SM
    CNS Spectr; 2014 Dec; 19 Suppl 1():57-67; quiz 54-7, 68. PubMed ID: 25544378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The under-recognized role of dopamine in the treatment of major depressive disorder.
    Montgomery SA
    Int Clin Psychopharmacol; 2008 Mar; 23(2):63-9. PubMed ID: 18301120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serotonin-dopamine interactions: implications for the design of novel therapeutic agents for psychiatric disorders.
    Wood MD; Wren PB
    Prog Brain Res; 2008; 172():213-30. PubMed ID: 18772035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. May selective serotonin reuptake inhibitors (SSRIs) provide some benefit for the treatment of schizophrenia?
    Buoli M; Serati M; Ciappolino V; Altamura AC
    Expert Opin Pharmacother; 2016 Jul; 17(10):1375-85. PubMed ID: 27148641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Other Antidepressants.
    Schwasinger-Schmidt TE; Macaluso M
    Handb Exp Pharmacol; 2019; 250():325-355. PubMed ID: 30194544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sumatriptan in clinical practice: effectiveness in migraine and the problem of psychiatric comorbidity.
    Napoletano F; Lionetto L; Martelletti P
    Expert Opin Pharmacother; 2014 Feb; 15(3):303-5. PubMed ID: 24206090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extrapyramidal symptoms with selective serotonin reuptake inhibitors.
    Arya DK
    Br J Psychiatry; 1994 Dec; 165(6):728-33. PubMed ID: 7881774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The patient under antidepressive and antipsychotic therapy].
    Hummel J; Lederbogen F
    MMW Fortschr Med; 2006 May; Spec no. 2():11-5; quiz 16. PubMed ID: 20104708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Neurobiology and pharmacotherapy of social phobia].
    Aouizerate B; Martin-Guehl C; Tignol J
    Encephale; 2004; 30(4):301-13. PubMed ID: 15538306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical evidence and potential neurobiological underpinnings of unresolved symptoms of depression.
    Trivedi MH; Hollander E; Nutt D; Blier P
    J Clin Psychiatry; 2008 Feb; 69(2):246-58. PubMed ID: 18363453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The serotonin transporter in psychiatric disorders: insights from PET imaging.
    Spies M; Knudsen GM; Lanzenberger R; Kasper S
    Lancet Psychiatry; 2015 Aug; 2(8):743-755. PubMed ID: 26249305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A role for Akt and glycogen synthase kinase-3 as integrators of dopamine and serotonin neurotransmission in mental health.
    Beaulieu JM
    J Psychiatry Neurosci; 2012 Jan; 37(1):7-16. PubMed ID: 21711983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined treatment strategies in psychiatry.
    Nelson JC
    J Clin Psychiatry; 1993 Sep; 54 Suppl():42-9; discussion 55-6. PubMed ID: 8104933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multifunctional pharmacotherapy: what can we learn from study of selective serotonin reuptake inhibitor augmentation of antipsychotics in negative-symptom schizophrenia?
    Silver H; Chertkow Y; Weinreb O; Danovich L; Youdim M
    Neurotherapeutics; 2009 Jan; 6(1):86-93. PubMed ID: 19110201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Psychopharmacological treatment of behavioral and psychological symptoms in dementia].
    Lolk A; Gulmann NC
    Ugeskr Laeger; 2006 Oct; 168(40):3429-32. PubMed ID: 17032610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmaco-economic aspects of antidepressants and antipsychotic drugs].
    Laux G
    Psychiatr Prax; 2003 May; 30 Suppl 2():S90-3. PubMed ID: 14509049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Organic Cation Transporters in Psychiatric Disorders.
    Daws LC
    Handb Exp Pharmacol; 2021; 266():215-239. PubMed ID: 34282486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel psychotropic medications in children: new toxicities to master.
    Jacobs ES; Dickstein DP; Liebelt EL
    Pediatr Emerg Care; 2001 Jun; 17(3):226-31. PubMed ID: 11437154
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.